This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
DOLE or CTVA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Wall Street Analysts Believe Dole (DOLE) Could Rally 36.4%: Here's is How to Trade
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 36.4% in Dole (DOLE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Best Income Stocks to Buy for November 20th
by Zacks Equity Research
DOLE and TM made it to the Zacks Rank #1 (Strong Buy) income stocks list on November 20, 2023.
Best Value Stocks to Buy for November 20th
by Zacks Equity Research
ACGL, DFH and DOLE made it to the Zacks Rank #1 (Strong Buy) value stocks list on November 20, 2023.
Dole (DOLE) Q3 Earnings Top Estimates
by Zacks Equity Research
Dole (DOLE) delivered earnings and revenue surprises of 118.18% and 2.49%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Corteva, Inc. (CTVA) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Corteva, Inc. (CTVA) delivered earnings and revenue surprises of 11.54% and 3.26%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Dole (DOLE) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Dole (DOLE) stock based on the movements in the options market lately.
Best Income Stocks to Buy for September 18th
by Zacks Equity Research
WRK, LRCX and DOLE made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 18, 2023.
All You Need to Know About Dole (DOLE) Rating Upgrade to Strong Buy
by Zacks Equity Research
Dole (DOLE) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
New Strong Buy Stocks for September 15th
by Zacks Equity Research
SWRAY, FISI, DOLE, ASBFY and SNPS have been added to the Zacks Rank #1 (Strong Buy) List on September 15, 2023.
Zacks Industry Outlook Highlights Archer Daniels Midland, Adecoagro, Dole and Limoneira
by Zacks Equity Research
Archer Daniels Midland, Adecoagro, Dole and Limoneira are part of the Zacks Industry Outlook article.
4 Stocks to Watch as the Agriculture Operations Industry Recovers
by Rajani Lohia
Agriculture - Operations industry is well-poised to gain on solid product portfolios and innovation in the near term, offset by impacts of raw material and commodity price inflation. Companies like ADM, AGRO, DOLE and LMNR stand to gain.
Is Coca-Cola HBC (CCHGY) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Coca-Cola HBC (CCHGY) and Dole (DOLE) have performed compared to their sector so far this year.
DOLE vs. CTVA: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?
Dole (DOLE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Dole (DOLE) delivered earnings and revenue surprises of 37.84% and 3.86%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Alico (ALCO) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Alico (ALCO) delivered earnings and revenue surprises of -1,012.50% and 53.01%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
S&W Seed (SANW) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
S&W Seed (SANW) delivered earnings and revenue surprises of 0% and 15.90%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Calavo Growers (CVGW) Reports Q1 Loss, Lags Revenue Estimates
by Zacks Equity Research
Calavo (CVGW) delivered earnings and revenue surprises of -133.33% and 18.21%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Dole (DOLE) Moves 7.8% Higher: Will This Strength Last?
by Zacks Equity Research
Dole (DOLE) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Dole (DOLE) Surpasses Q3 Earnings Estimates
by Zacks Equity Research
Dole (DOLE) delivered earnings and revenue surprises of 55.56% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Metabolix, Inc. (YTEN) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Metabolix, Inc. (YTEN) delivered earnings and revenue surprises of -1.43% and 26%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Dole Q2 Preview: Can Shares Find New Life?
by Derek Lewis
Over the market's rally over the last month, Dole shares have lagged notably, decreasing by 4% in value.
Do Options Traders Know Something About Dole (DOLE) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Dole (DOLE) stock based on the movements in the options market lately.
Are Options Traders Betting on a Big Move in Dole (DOLE) Stock?
by Zacks Equity Research
Investors need to pay close attention to Dole (DOLE) stock based on the movements in the options market lately.
DOLE vs. CTVA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
DOLE vs. CTVA: Which Stock Is the Better Value Option?